Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/15820
Title: Regulation of DNA (Cytosine-5) Methyltransferase 1 in the cell cycle and its role(s) in doxorubicin-mediated micronuclei formation
Authors: TAN HWEE HONG
Keywords: DNMT1, p21WAF1, p300, transcription, doxorubicin, micronuclei.
Issue Date: 14-May-2009
Source: TAN HWEE HONG (2009-05-14). Regulation of DNA (Cytosine-5) Methyltransferase 1 in the cell cycle and its role(s) in doxorubicin-mediated micronuclei formation. ScholarBank@NUS Repository.
Abstract: The expression of DNMT1 is critical in coordinating DNMT1 activity with biological processes and therefore must be tightly regulated in the cell cycle. Several studies have shown that DNMT1 expression level is inversely correlated with p21WAF1 protein, but the exact mechanism remained unresolved. Interestingly, I identified p21WAF1 as a novel upstream regulator of DNMT1 expression in mammalian cell lines. p300, which serves as a crucial transcription co-activator for DNMT1, emerged as an important mediator for the negative regulation of DNMT1 by p21WAF1. Aside from elucidating the mechanism involved in regulating DNMT1, the involvement of DNMT1 in DNA damage response was studied. Doxorubicin can induce the formation of extranuclear bodies during mitosis termed micronuclei, but the underlying causes remain unknown. Interestingly, my work provides strong evidence for the involvement of DNMT1 in promoting genomic instability in the form of micronuclei formation in human cancer cells upon sub-lethal exposure to doxorubicin.
URI: http://scholarbank.nus.edu.sg/handle/10635/15820
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
Regulation of DNMT1 and its role in micronuclei formation.pdf4.44 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

260
checked on Dec 11, 2017

Download(s)

276
checked on Dec 11, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.